150 related articles for article (PubMed ID: 19430167)
1. Effective use of microdosing and Positron Emission Tomography (PET) studies on new drug discovery and development.
Sugiyama Y
Drug Metab Pharmacokinet; 2009; 24(2):127-9. PubMed ID: 19430167
[No Abstract] [Full Text] [Related]
2. Can positron emission tomography facilitate paediatric drug development?
Zimmer L
Fundam Clin Pharmacol; 2008 Dec; 22(6):595-8. PubMed ID: 19049660
[TBL] [Abstract][Full Text] [Related]
3. Microdosing studies in humans: the role of positron emission tomography.
Bauer M; Wagner CC; Langer O
Drugs R D; 2008; 9(2):73-81. PubMed ID: 18298126
[TBL] [Abstract][Full Text] [Related]
4. Microdosing for early biokinetic studies in humans.
Stenström K; Sydoff M; Mattsson S
Radiat Prot Dosimetry; 2010; 139(1-3):348-52. PubMed ID: 20167793
[TBL] [Abstract][Full Text] [Related]
5. Trends in microdosing and other exploratory human pharmacokinetic studies for early drug development.
Oosterhuis B
Bioanalysis; 2010 Mar; 2(3):377-9. PubMed ID: 21083246
[No Abstract] [Full Text] [Related]
6. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
7. [Consideration on molecular imaging technology as a tool for drug research and development].
Yajima K; Nishimura S
Yakugaku Zasshi; 2009 Mar; 129(3):297-304. PubMed ID: 19252387
[TBL] [Abstract][Full Text] [Related]
8. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery.
Zimmer L
Expert Opin Drug Discov; 2024 Feb; 19(2):161-172. PubMed ID: 37948046
[TBL] [Abstract][Full Text] [Related]
9. [Molecular imaging-based early-phase and exploratory clinical research].
Watanabe Y
Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
[TBL] [Abstract][Full Text] [Related]
10. Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.
Burt T; John CS; Ruckle JL; Vuong LT
Expert Opin Drug Deliv; 2017 May; 14(5):657-672. PubMed ID: 27564533
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.
Bergström M; Grahnén A; Långström B
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873
[TBL] [Abstract][Full Text] [Related]
12. PET as a Translational Tool in Drug Development for Neuroscience Compounds.
Varrone A; Bundgaard C; Bang-Andersen B
Clin Pharmacol Ther; 2022 Apr; 111(4):774-785. PubMed ID: 35201613
[TBL] [Abstract][Full Text] [Related]
13. The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals.
Roselt P; Meikle S; Kassiou M
Eur J Drug Metab Pharmacokinet; 2004; 29(1):1-6. PubMed ID: 15151164
[TBL] [Abstract][Full Text] [Related]
14. Microdosing, isotopic labeling, radiotracers and metabolomics: relevance in drug discovery, development and safety.
Wotherspoon AT; Safavi-Naeini M; Banati RB
Bioanalysis; 2017 Dec; 9(23):1913-1933. PubMed ID: 29171759
[TBL] [Abstract][Full Text] [Related]
15. [Application of pre-clinical PET imaging for drug development].
Tsukada H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in CNS drug discovery and drug monitoring.
Piel M; Vernaleken I; Rösch F
J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
[TBL] [Abstract][Full Text] [Related]
17. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
Bauer M; Langer O; Dal-Bianco P; Karch R; Brunner M; Abrahim A; Lanzenberger R; Hofmann A; Joukhadar C; Carminati P; Ghirardi O; Piovesan P; Forloni G; Corrado ME; Lods N; Dudczak R; Auff E; Kletter K; Müller M
Clin Pharmacol Ther; 2006 Sep; 80(3):216-27. PubMed ID: 16952488
[TBL] [Abstract][Full Text] [Related]
18. [Applications of PET imaging in the preclinical stage of drug development].
Tsukada H
Nihon Yakurigaku Zasshi; 2010 Feb; 135(2):80-3. PubMed ID: 20154416
[No Abstract] [Full Text] [Related]
19. Animal tumor models for PET in drug development.
Toyohara J; Ishiwata K
Ann Nucl Med; 2011 Dec; 25(10):717-31. PubMed ID: 21879295
[TBL] [Abstract][Full Text] [Related]
20. Translational PET imaging research.
Hargreaves RJ; Rabiner EA
Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
